Genitourinary Drugs Market Research Report - Global Forecast till 2023

1. Market Research Future Genitourinary Drugs are used for the treatment of medical complications related to the kidney, bladder, ureter, and urethra. Genitourinary disorders are caused by damage to the urinary tract or genital organs. The global genitourinary drugs market accounted for USD 28,200 million in 2016 and is expected to register a CAGR of ~1.65% during the forecast period from 2018 to 2023. Genitourinary disorders are caused by damage to the urinal or genital part of the human body. Kidney, bladder, ureter, and urethra are parts of the genitourinary system. Genitourinary drugs are used to treat medical complications caused to these parts. The rising prevalence of genitourinary disorders, increasing number of pipeline drugs, and technological advancements in genitourinary diagnosis are expected to drive the growth of the market. According to the US National Library of Medicine, more than 480 clinical trials are lined up for the treatment of urinary tract infection. Get Sample Research Report at https://www.marketresearchfuture.com/sample_request/6802 Regional Analysis: Americas is expected to dominate the global genitourinary drugs market during the forecast period owing to the rising prevalence of genitourinary disorders, increasing number of cancer patients in the region, the rise in healthcare expenditure, and the presence of a well-established healthcare system. The European market is expected to be the second-largest due to government initiatives for the development of the healthcare sector, increasing research and development activities in the region, and the rise in a number of chronic disorders. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing market during the forecast period owing to the increasing geriatric population, rising investments in the healthcare sector, and favorable government policies. The market in the Middle East and Africa is likely to account for the smallest share of the global genitourinary drugs market. https://www.marketresearchfuture.com

2. Market Research Future Key Players: Some of the key players in the global genitourinary drugs market are Bayer AG, AstraZeneca, Abbott, Astellas Pharma Inc., Pfizer Inc., Eli Lilly and Company, Genentech, Inc., Immunex Corp. GlaxoSmithKline plc., Ionis Pharmaceuticals, Inc., Merck & Co., Bristol-Myers Squibb Company, Antares Pharma, and Novartis AG. Genitourinary disorders are caused by damage to the urinal or genital part of the human body. Kidney, bladder, ureter, and urethra are parts of the genitourinary system. Genitourinary drugs are used to treat medical complications caused to these parts. The rising prevalence of genitourinary disorders, increasing number of pipeline drugs, and technological advancements in genitourinary diagnosis are expected to drive the growth of the market. According to the US National Library of Medicine, more than 480 clinical trials are lined up for the treatment of urinary tract infection. Rising R&D spending and collaborative strategies such as licensing and agreements adopted by top players are contributing to the growth of the market. For instance, in October 2018, Novartis AG signed a licensing agreement with Boston Pharmaceuticals for manufacturing and marketing its three anti-infective products, namely, LYS228, IID572, and MAK181. The increasing emergence of counterfeit drugs, rising generics drug competition, and a high number of patent expirations may hamper the growth of the market during the assessment period. Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/genitourinary- drugs-market-6802 Segmentation: The global genitourinary drugs market has been segmented on the basis of disease, product, and end user. https://www.marketresearchfuture.com

3. Market Research Future The market, by disease, has been classified as urinary tract infections, erectile dysfunction, urinary incontinence and overactive bladder, kidney/renal cancer, genitourinary cancer, bladder cancer, bladder cancer, cervical cancer, sexually transmitted diseases, interstitial cystitis, hematuria, ovarian cancer, and prostate cancer. On the basis of product, the market has been segregated into urological, hormonal therapy, gynecological, and anti-infectives. The end user segment has been divided into, hospitals, clinics, super specialty centers, and others. Inquire for Discount at https://www.marketresearchfuture.com/check- discount/6802 About Market Research Future:MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune +1 646 845 9312 Email: sales@marketresearchfuture.com https://www.marketresearchfuture.com